FTC
Illumina to Divest Grail After US Appeals Court Sends Case Back to FTC
The sequencing instrument maker said it plans to finalize terms for a sale or IPO by the end of the second quarter of 2024.
Illumina Appeals FTC's Order to Divest Grail, Cites Government Overreach
In its petitioner's brief, Illumina and Grail called the FTC an "unconstitutional agency" and ask the court to revers the commission's decision.
US Federal Trade Commission Orders Illumina to Unwind Grail Acquisition
Illumina plans to appeal the decision, seeking a resolution by late 2023 or early 2024, but now faces a third source of pressure to divest Grail.
EU to Disallow Illumina's Grail Purchase
Separately, the US Federal Trade Commission said it will appeal an administrative law judge's initial decision in an antitrust case that was favorable to Illumina.
Illumina Says Judge Issued Favorable Decision in FTC Challenge to Grail Acquisition
According to the firm, the judge "rejected the FTC's position that the deal would adversely affect competition" of multi-cancer early detection tests.